ArticleScientific reports2017

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.

Levi J Rupp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.